Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial Seizure”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00236730
What this trial is testing

The Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 178
Not applicableStudy completedNCT04257604
What this trial is testing

Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures

Who this might be right for
Partial Seizures
Eisai Limited 243
Large-scale testing (Phase 3)Study completedNCT03201900
What this trial is testing

Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study)

Who this might be right for
Partial Onset Seizures
Eisai Co., Ltd. 91
Post-approval studies (Phase 4)Study completedNCT00351611
What this trial is testing

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Who this might be right for
Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 187
Large-scale testing (Phase 3)Study completedNCT00530855
What this trial is testing

Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 322
Post-approval studies (Phase 4)Study completedNCT02705768
What this trial is testing

Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures

Who this might be right for
Seizures, Focal
All India Institute of Medical Sciences, Bhubaneswar 90
Large-scale testing (Phase 3)Study completedNCT00615615
What this trial is testing

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 216
Not applicableStudy completedNCT02736162
What this trial is testing

Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

Who this might be right for
EpilepsyPartial-Onset SeizuresPrimary Generalized Tonic-Clonic Seizures
Eisai Inc. 61
Large-scale testing (Phase 3)Study completedNCT00113165
What this trial is testing

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Who this might be right for
EpilepsyEpilepsy, Partial
GlaxoSmithKline 244
Large-scale testing (Phase 3)Study completedNCT00700310
What this trial is testing

Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Who this might be right for
Refractory Partial Seizures
Eisai Inc. 712
Not applicableStudy completedNCT00922987
What this trial is testing

Clinical Study With Lyrica In Patients Suffering From Epilepsy

Who this might be right for
NeuralgiaEpilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 286
Testing effectiveness (Phase 2)Study completedNCT00416195
What this trial is testing

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Co., Ltd. 48
Early research (Phase 1)Study completedNCT00233012
What this trial is testing

The Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

Who this might be right for
Seizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 16
Testing effectiveness (Phase 2)Study completedNCT06377930
What this trial is testing

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Who this might be right for
Focal Onset Seizures
Rapport Therapeutics Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT01496612
What this trial is testing

Buspirone Therapy for Localized Epilepsy

Who this might be right for
Anxiety DisorderSeizuresEpilepsy+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 9
Not applicableUnknownNCT04737837
What this trial is testing

A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy

Who this might be right for
EpilepsyFocal-Onset Seizure
Jiangxi Qingfeng Pharmaceutical Co. Ltd. 200
Not applicableStudy completedNCT01830868
What this trial is testing

A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)

Who this might be right for
Partial Onset Seizures
Eisai Inc. 104
Testing effectiveness (Phase 2)Study completedNCT01179854
What this trial is testing

Remegal Different Doses in Patients With Refractory Partial Seizures

Who this might be right for
Drug SafetyNormal Drug ToleranceSelf Efficacy
Valexfarm 60
Early research (Phase 1)Active Not RecruitingNCT06899230
What this trial is testing

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007

Who this might be right for
Drug Resistant EpilepsyFocal Seizure
iQure Australia Pty Ltd 72
Large-scale testing (Phase 3)Study completedNCT00113815
What this trial is testing

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Who this might be right for
Partial Seizure DisorderEpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 118
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation